- Home
- SBCF vs HAE Comparison
SBCF vs HAE Comparison
Compare SBCF & HAE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SBCF
- HAE
- Stock Information
- Founded
- SBCF 1926
- HAE 1971
- Country
- SBCF United States
- HAE United States
- Employees
- SBCF N/A
- HAE N/A
- Industry
- SBCF Major Banks
- HAE Medical/Dental Instruments
- Sector
- SBCF Finance
- HAE Health Care
- Exchange
- SBCF Nasdaq
- HAE Nasdaq
- Market Cap
- SBCF 3.0B
- HAE 2.4B
- IPO Year
- SBCF N/A
- HAE 1991
- Fundamental
- Price
- SBCF $31.44
- HAE $51.38
- Analyst Decision
- SBCF Buy
- HAE Buy
- Analyst Count
- SBCF 4
- HAE 8
- Target Price
- SBCF $29.50
- HAE $76.88
- AVG Volume (30 Days)
- SBCF 556.9K
- HAE 695.5K
- Earning Date
- SBCF 10-27-2025
- HAE 11-06-2025
- Dividend Yield
- SBCF 2.29%
- HAE N/A
- EPS Growth
- SBCF 19.16
- HAE 46.89
- EPS
- SBCF 1.63
- HAE 3.28
- Revenue
- SBCF $531,697,000.00
- HAE $1,346,046,000.00
- Revenue This Year
- SBCF $28.39
- HAE N/A
- Revenue Next Year
- SBCF $34.82
- HAE $6.42
- P/E Ratio
- SBCF $19.26
- HAE $15.66
- Revenue Growth
- SBCF 5.40
- HAE 0.91
- 52 Week Low
- SBCF $21.36
- HAE $47.32
- 52 Week High
- SBCF $32.33
- HAE $94.99
- Technical
- Relative Strength Index (RSI)
- SBCF 56.55
- HAE 51.54
- Support Level
- SBCF $29.83
- HAE $50.30
- Resistance Level
- SBCF $30.74
- HAE $51.89
- Average True Range (ATR)
- SBCF 0.98
- HAE 1.41
- MACD
- SBCF -0.01
- HAE 0.54
- Stochastic Oscillator
- SBCF 83.14
- HAE 81.12
About SBCF Seacoast Banking Corporation of Florida
Seacoast Banking Corp of Florida is a holding company for Seacoast National Bank. The company provides integrated financial services including commercial and consumer banking, wealth management, and mortgage and insurance services to customers across Florida, and through mobile and online banking solutions. In addition, it provides services such as treasury management, brokerage and credit facilities.
About HAE Haemonetics Corporation
Haemonetics Corp aims to improve patient care and reduce the cost of healthcare by providing medical products and solutions in the blood and plasma component collection, surgical suite, and hospital transfusion service spaces. As such, the company operates under three segments: plasma, blood center, and hospital. The company primarily emphasizes its plasma and hospital segments due to their robust growth potential, whereas the blood center segment tends to be constrained by higher competition. Product revenue is driven by demand for disposable blood component collection and processing sets and the related equipment needed for proper functionality.